Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) Operating Margin: 2022-2025

Historic Operating Margin for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Sep 2025 value amounting to 1,861.25%.

  • Centessa Pharmaceuticals' Operating Margin rose 4642.00% to 1,861.25% in Q3 2025 from the same period last year, while for Sep 2025 it was -3,168.82%, marking a year-over-year decrease of 475661.00%. This contributed to the annual value of 1,992.62% for FY2024, which is 449200.00% up from last year.
  • As of Q3 2025, Centessa Pharmaceuticals' Operating Margin stood at 1,861.25%, which was down 1.78% from 1,895.04% recorded in Q2 2025.
  • In the past 5 years, Centessa Pharmaceuticals' Operating Margin ranged from a high of 4,138.78% in Q2 2022 and a low of -205.18% during Q1 2025.
  • For the 3-year period, Centessa Pharmaceuticals' Operating Margin averaged around 1,681.63%, with its median value being 1,814.82% (2024).
  • Per our database at Business Quant, Centessa Pharmaceuticals' Operating Margin slumped by 221,964bps in 2023 and then spiked by 163,968bps in 2024.
  • Centessa Pharmaceuticals' Operating Margin (Quarterly) stood at 1,888.47% in 2022, then slumped by 51,968bps to 1,368.79% in 2023, then surged by 163,968bps to 3,008.47% in 2024, then skyrocketed by 4,642bps to 1,861.25% in 2025.
  • Its Operating Margin was 1,861.25% in Q3 2025, compared to 1,895.04% in Q2 2025 and -205.18% in Q1 2025.